A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ.

Squamous cell carcinoma in situ is an intra-epidermal malignancy of the skin with potential to progress to invasive carcinoma. Commonly used treatments are surgical excision, cryotherapy, photodynamic therapy, laser ablation, curettage with cautery, radiotherapy, topical 5-fluorouracil, and topical imiquimod. The efficacies of these different treatment modalities are compared in this retrospective study of 239 patients with squamous cell carcinoma in situ diagnosed and treated at our hospital during a period of one year. A total of 263 histologically confirmed in situ lesions were followed up for approximately 8 years. The overall recurrence rate was 6.5%. Surgical excision had the lowest recurrence rate, at 0.8%. Recurrence rates with the less-invasive treatment modalities were markedly higher; cryotherapy 4.7% and photodynamic therapy 18%. Of all recurrences, 65% were carcinoma in situ and 35% squamous cell carcinomas. Twenty-three patients had actinic keratosis in the area treated, but these were not counted as recurrences. In conclusion, excisional surgery is the gold standard treatment for squamous cell carcinoma in situ, although it has limitations. Less invasive methods may sometimes be preferred.

[1]  L. Jeskanen,et al.  [Basal cell carcinoma, squamous cell carcinoma and premalignant skin lesions--how to treat?]. , 2014, Duodecim; laaketieteellinen aikakauskirja.

[2]  P. Nelemans,et al.  Bowen's disease: A six-year retrospective study of treatment with emphasis on resection margins. , 2014, Acta dermato-venereologica.

[3]  J. Leonardi-Bee,et al.  Interventions for cutaneous Bowen's disease. , 2013, The Cochrane database of systematic reviews.

[4]  R. Dufresne,et al.  Treatment of Squamous Cell Carcinoma In Situ: A Review , 2011, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[5]  P. Lehmann.  Methyl aminolaevulinate–photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer , 2007, The British journal of dermatology.

[6]  D. Eedy,et al.  Guidelines for management of Bowen's disease: 2006 update , 2007, The British journal of dermatology.

[7]  H. Kerl,et al.  Guidelines for the management of actinic keratoses. , 2006, European journal of dermatology : EJD.

[8]  P. Wolf,et al.  Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial. , 2006, Archives of dermatology.

[9]  C. Morton,et al.  Randomized comparison of photodynamic therapy with topical 5‐fluorouracil in Bowen's disease , 2003, The British journal of dermatology.

[10]  Morton,et al.  Guidelines for management of Bowen's disease , 1999, The British journal of dermatology.

[11]  J. L. Stone,et al.  Bowen's disease (squamous cell carcinoma in situ) in Kauai, Hawaii. A population-based incidence report. , 1994, Journal of the American Academy of Dermatology.